| Primary |
| Product Used For Unknown Indication |
29.0% |
| Drug Use For Unknown Indication |
10.9% |
| Cytomegalovirus Infection |
10.2% |
| Immunosuppression |
7.9% |
| Hiv Infection |
7.8% |
| Burkitt's Lymphoma |
5.2% |
| Renal Transplant |
5.0% |
| Antiviral Prophylaxis |
3.6% |
| Prophylaxis |
2.9% |
| Lung Transplant |
2.8% |
| Liver Transplant |
2.6% |
| Hypertension |
2.4% |
| Prophylaxis Against Transplant Rejection |
2.2% |
| Heart Transplant |
1.9% |
| Transplant |
1.4% |
| Cytomegalovirus Chorioretinitis |
1.2% |
| Immunosuppressant Drug Therapy |
0.9% |
| Congenital Cytomegalovirus Infection |
0.7% |
| Epstein-barr Virus Infection |
0.7% |
| Pneumonia |
0.7% |
|
| Death |
53.4% |
| Cytomegalovirus Infection |
4.0% |
| Thrombocytopenia |
3.6% |
| Transplant Rejection |
3.6% |
| Hospitalisation |
2.8% |
| Malaise |
2.8% |
| Sepsis |
2.8% |
| Platelet Count Decreased |
2.4% |
| Pneumocystis Jiroveci Pneumonia |
2.4% |
| Vomiting |
2.4% |
| Weight Decreased |
2.4% |
| Cerebrovascular Accident |
2.0% |
| Cytomegalovirus Colitis |
2.0% |
| Leukopenia |
2.0% |
| Pneumonia |
2.0% |
| Pneumonitis |
2.0% |
| White Blood Cell Count Decreased |
2.0% |
| Drug Resistance |
1.6% |
| Haemolytic Anaemia |
1.6% |
| Osteonecrosis |
1.6% |
|
| Secondary |
| Renal Transplant |
16.2% |
| Drug Use For Unknown Indication |
16.1% |
| Product Used For Unknown Indication |
12.6% |
| Hiv Infection |
11.8% |
| Immunosuppression |
9.9% |
| Cytomegalovirus Infection |
5.4% |
| Hypertension |
4.9% |
| Prophylaxis Against Transplant Rejection |
4.5% |
| Drug Exposure During Pregnancy |
2.4% |
| Prophylaxis |
2.2% |
| Liver Transplant |
2.0% |
| Urinary Tract Infection |
2.0% |
| Gastritis |
1.5% |
| Cytomegalovirus Chorioretinitis |
1.4% |
| Pain |
1.4% |
| Opportunistic Infection Prophylaxis |
1.4% |
| Depression |
1.1% |
| Pneumonia |
1.0% |
| Acquired Immunodeficiency Syndrome |
1.0% |
| Antiviral Prophylaxis |
1.0% |
|
| Death |
16.6% |
| Transplant Rejection |
9.6% |
| Thrombocytopenia |
8.0% |
| Osteonecrosis |
5.9% |
| Pyrexia |
5.9% |
| White Blood Cell Count Decreased |
5.9% |
| Agranulocytosis |
4.3% |
| Cytomegalovirus Infection |
4.3% |
| Leukopenia |
4.3% |
| Neural Tube Defect |
4.3% |
| Neutropenia |
4.3% |
| Diarrhoea |
3.7% |
| Febrile Neutropenia |
3.7% |
| Pancytopenia |
3.7% |
| Tubulointerstitial Nephritis |
3.2% |
| Cytomegalovirus Chorioretinitis |
2.7% |
| Decreased Appetite |
2.7% |
| Pregnancy |
2.7% |
| Bronchopulmonary Aspergillosis |
2.1% |
| Concomitant Disease Progression |
2.1% |
|
| Concomitant |
| Product Used For Unknown Indication |
36.8% |
| Renal Transplant |
12.3% |
| Drug Use For Unknown Indication |
9.9% |
| Prophylaxis Against Transplant Rejection |
7.8% |
| Prophylaxis |
5.1% |
| Hiv Infection |
4.1% |
| Hypertension |
3.9% |
| Immunosuppression |
3.0% |
| Pain |
2.2% |
| Liver Transplant |
2.2% |
| Infection Prophylaxis |
1.9% |
| Antiviral Prophylaxis |
1.7% |
| Nuclear Magnetic Resonance Imaging |
1.4% |
| Antifungal Prophylaxis |
1.3% |
| Kidney Transplant Rejection |
1.2% |
| Cytomegalovirus Infection |
1.2% |
| Heart Transplant |
1.1% |
| Diabetes Mellitus |
1.1% |
| Nausea |
1.0% |
| Depression |
0.8% |
|
| Vomiting |
12.3% |
| White Blood Cell Count Decreased |
9.1% |
| Pyrexia |
8.8% |
| Urinary Tract Infection |
7.5% |
| Transplant Rejection |
7.1% |
| Thrombocytopenia |
6.0% |
| Death |
5.2% |
| Renal Failure Acute |
4.7% |
| Septic Shock |
4.5% |
| Pneumonia |
4.1% |
| Weight Decreased |
3.9% |
| Leukopenia |
3.7% |
| Urosepsis |
3.7% |
| Rash |
3.0% |
| Upper Respiratory Tract Infection |
3.0% |
| Kidney Transplant Rejection |
2.8% |
| Liver Transplant Rejection |
2.8% |
| Renal Failure |
2.8% |
| Diarrhoea |
2.6% |
| Neutropenia |
2.4% |
|
| Interacting |
| Product Used For Unknown Indication |
98.0% |
| Analgesic Therapy |
2.0% |
|
| Agranulocytosis |
50.0% |
| Rhabdomyolysis |
50.0% |
|
